Oh MD - Search Results

1

Remdesivir for the Treatment of Covid-19 - Final Report.

Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, Fätkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC; ACTT-1 Study Group Members. Beigel JH, et al. Among authors: oh md. N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8. N Engl J Med. 2020. PMID: 32445440 Free PMC article. Clinical Trial.

2

Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in Korea.

Kim HB, Park WB, Lee KD, Choi YJ, Park SW, Oh MD, Kim EC, Choe KW. Kim HB, et al. Among authors: oh md. J Clin Microbiol. 2003 Jun;41(6):2279-81. doi: 10.1128/JCM.41.6.2279-2281.2003. J Clin Microbiol. 2003. PMID: 12791836 Free PMC article.

3

In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey.

Kim HB, Jang HC, Nam HJ, Lee YS, Kim BS, Park WB, Lee KD, Choi YJ, Park SW, Oh MD, Kim EC, Choe KW. Kim HB, et al. Among authors: oh md. Antimicrob Agents Chemother. 2004 Apr;48(4):1124-7. doi: 10.1128/AAC.48.4.1124-1127.2004. Antimicrob Agents Chemother. 2004. PMID: 15047511 Free PMC article.

4

Risk Factors for Ciprofloxacin Resistance in Bloodstream Infections Due to Extended-Spectrum beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae.

Kang CI, Kim SH, Kim DM, Park WB, Lee KD, Kim HB, Oh MD, Kim EC, Choe KW. Kang CI, et al. Among authors: oh md. Microb Drug Resist. 2004 Spring;10(1):71-6. doi: 10.1089/107662904323047835. Microb Drug Resist. 2004. PMID: 15140397

5

Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae.

Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB, Kim EC, Oh MD, Choe KW. Pai H, et al. Among authors: oh md. Antimicrob Agents Chemother. 2004 Oct;48(10):3720-8. doi: 10.1128/AAC.48.10.3720-3728.2004. Antimicrob Agents Chemother. 2004. PMID: 15388426 Free PMC article.

6

Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.

Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Oh MD, Kim EC, Choe KW. Kang CI, et al. Among authors: oh md. Clin Infect Dis. 2004 Sep 15;39(6):812-8. doi: 10.1086/423382. Epub 2004 Aug 25. Clin Infect Dis. 2004. PMID: 15472813

7

Clinical outcome of bacteremic spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Oh MD, Kim EC, Lee HS, Choe KW. Kang CI, et al. Among authors: oh md. Korean J Intern Med. 2004 Sep;19(3):160-4. doi: 10.3904/kjim.2004.19.3.160. Korean J Intern Med. 2004. PMID: 15481607 Free PMC article.

8

Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.

Kang CI, Kim SH, Kim DM, Park WB, Lee KD, Kim HB, Oh MD, Kim EC, Choe KW. Kang CI, et al. Among authors: oh md. Infect Control Hosp Epidemiol. 2004 Oct;25(10):860-7. doi: 10.1086/502310. Infect Control Hosp Epidemiol. 2004. PMID: 15518030

9

Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.

Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. Kang CI, et al. Among authors: oh md. Antimicrob Agents Chemother. 2004 Dec;48(12):4574-81. doi: 10.1128/AAC.48.12.4574-4581.2004. Antimicrob Agents Chemother. 2004. PMID: 15561828 Free PMC article.

10

Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.

Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. Kang CI, et al. Among authors: oh md. Antimicrob Agents Chemother. 2005 Feb;49(2):760-6. doi: 10.1128/AAC.49.2.760-766.2005. Antimicrob Agents Chemother. 2005. PMID: 15673761 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

356 results

Search Page

Filters